Abstract Body

Over the past decade, our studies found that HIV-1 latency is driven by stochastic fluctuations in Tat transcription (Weinberger et al. Cell 2005), which provided the first evidence for a classic theory that transcriptional fluctuations (a.k.a., ‘noise’) are harnessed for cell-fate decisions. We subsequently characterized a ‘hardwired’ virus-intrinsic HIV circuit that regulates latency and appears optimized by evolution (Razooky et al. Cell 2015; Rouzine et al. Cell 2015). Our studies also found FDA-approved compounds that act as noise-enhancer molecules and potentiate current LRAs, dramatically increasing their potency (Dar et al. PNAS 2012; Dar et al. Science 2014). Recently, we discovered that HIV alternative splicing is post transcriptional, thereby generating a noise-attenuating circuit that regulates HIV’s latency decision (Hansen et al. Cell 2018). Perturbing the HIV latency circuit, for example with noise-enhancer or suppressor molecules, may represent a novel strategy for HIV cure, and functional cure, approaches.